pmid,doi,title,journal,year,abstract_length,methods_length,intro_length,existing_tool_count,novel_tool_count,total_tool_count,existing_tools,novel_tools,tool_metadata,tool_sources,is_gff
10567424,10.1074/jbc.274.48.34438,Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF.,J Biol Chem,1999,1428,15631,4660,0,4,4,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [""PIPER-FlexPepDock""], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Rosetta"", ""GraphPad Prism"", ""Prism""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:PIPER-FlexPepDock"": {""cellLineCategory"": """", ""organ"": """", ""tissue"": """", ""is_development"": true, ""is_generic"": false}, ""computational_tools:Rosetta"": {""context"": ""further refined using the Rosetta FlexPepDock protocol, 41  including receptor backbone minimization, and\ntop-scoring models are clustered. In this study, all Rosetta simulations\nwere performed using Rosetta version 2019.14. The protocol is freely\navailable for noncommercial use as an online server:  42 https://piperfpd.furmanlab.cs.huji.ac.il . Peptide Threading with Rosetta FlexPepBind The FlexPepBind\nprotocol  uses a"", ""confidence"": 0.8, ""is_development"": false, ""is_generic"": false}, ""computational_tools:GraphPad Prism"": {""context"": ""P buffer, and\nthen an equal volume of 10 nM FITC-labeled peptide was added to each\nsample. After mixing, the FP signals were recorded using SpectraMax\niD5 (Molecular Devices). Data were analyzed with GraphPad Prism version\n7.0.0 for MacOS (GraphPad Software, San Diego, California USA). A\nquadratic equation for equilibrium binding  was used to fit the obtained data. 37 where  pept  indicates\nthe\nprobe peptide co"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false}, ""computational_tools:Prism"": {""context"": "" and\nthen an equal volume of 10 nM FITC-labeled peptide was added to each\nsample. After mixing, the FP signals were recorded using SpectraMax\niD5 (Molecular Devices). Data were analyzed with GraphPad Prism version\n7.0.0 for MacOS (GraphPad Software, San Diego, California USA). A\nquadratic equation for equilibrium binding  was used to fit the obtained data. 37 where  pept  indicates\nthe\nprobe peptide concentration (5"", ""confidence"": 0.8, ""is_development"": false, ""is_generic"": false}}","{""cell_lines:PIPER-FlexPepDock"": [""methods""], ""computational_tools:Rosetta"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:Prism"": [""methods""]}",False
10620616,10.1084/jem.191.1.181,Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo.,J Exp Med,2000,1916,5444,2211,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [""May-Grunwald-Giemsa""], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:May-Grunwald-Giemsa"": {""cellLineCategory"": """", ""organ"": """", ""tissue"": """", ""is_development"": true, ""is_generic"": false}}","{""cell_lines:May-Grunwald-Giemsa"": [""methods""]}",False
10627474,,Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors.,Blood,2000,1851,9212,3287,0,8,8,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [""Hi-Fi""], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""featureCounts"", ""Flow"", ""BWA"", ""ICE"", ""STAR"", ""DESeq2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [""NSG""], ""clinical_assessment_tools"": []}","{""cell_lines:Hi-Fi"": {""cellLineCategory"": ""Normal cell line"", ""organ"": """", ""tissue"": """", ""is_development"": true, ""is_generic"": false}, ""computational_tools:featureCounts"": {""context"": ""h38) using Spliced Transcripts Alignment to a Reference (STAR). Mapping quality was ensured, and alignment coverage was visually inspected in Partek Flow. Gene expression levels were quantified using featureCounts and normalized using transcripts per million (TPM). Differential analyses were performed on Partek Flow v12.3 software using DESeq2 package. Principal component analysis (PCA) and hierarchical cluste"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false}, ""computational_tools:Flow"": {""context"": ""ge was visually inspected in Partek Flow. Gene expression levels were quantified using featureCounts and normalized using transcripts per million (TPM). Differential analyses were performed on Partek Flow v12.3 software using DESeq2 package. Principal component analysis (PCA) and hierarchical clustering were performed on normalized counts to visualize expression patterns. Differentially expressed genes in s"", ""confidence"": 0.8, ""is_development"": false, ""is_generic"": false}, ""computational_tools:BWA"": {""context"": "", converted to FASTQ format, and filtered to remove adapter contamination, low-quality bases, and Ns. Filtered reads were aligned to the reference genome (b37/hg19/hg38) using Burrow-Wheeler Aligner (BWA) and sorted using Sambamba. Novogene\u2019s CRISPR-specific pipeline summarized all observed edits per guide RNA. To confirm on-target events and identify potential off-targets, we analyzed somatic single"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false}, ""computational_tools:ICE"": {""context"": ""GGAGACATGGTCA. PCR amplified product was sent for Sanger sequencing to Quintara Biosciences (South San Francisco, CA). The sequencing data were analyzed using the web-based inference of CRISPR edits (ICE v3) tool (Synthego). NF1  protein detection using WES We performed a Simple Western (WES) assay (ProteinSimple) to detect NF1 protein in NF1-KO and control UCB HSPCs. WES uses capillary electrophoresis "", ""confidence"": 0.8, ""is_development"": false, ""is_generic"": false}, ""computational_tools:STAR"": {""context"": ""rol steps, adapter trimming, and alignment were conducted using Partek Flow software, v12.3.  Reads were aligned to the whole human genome (GRCh38) using Spliced Transcripts Alignment to a Reference (STAR). Mapping quality was ensured, and alignment coverage was visually inspected in Partek Flow. Gene expression levels were quantified using featureCounts and normalized using transcripts per million (T"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false}, ""computational_tools:DESeq2"": {""context"": ""in Partek Flow. Gene expression levels were quantified using featureCounts and normalized using transcripts per million (TPM). Differential analyses were performed on Partek Flow v12.3 software using DESeq2 package. Principal component analysis (PCA) and hierarchical clustering were performed on normalized counts to visualize expression patterns. Differentially expressed genes in specific NF1-KO vs cont"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false}, ""patient_derived_models:NSG"": {""context"": ""U)-GEMM (granulocyte, erythroid, monocyte and megakaryocyte), CFU-GM (granulocyte macrophage), and CFU-E (Erythroid) colonies. Leukemia-initiating capacity of  NF1 -KO cells in humanized mice We used NSGS [NOD.Cg- Prkdc \n scid Il2rg  Tg(CMV-IL3,CSF2,KITLG)1Eav/MloySzJ] mice (Jackson laboratories, Strain# 013062) as recipients for  tm1Wjl NF1 -KO or control UCB HSPCs. All mice were housed in Stanford\u2019"", ""confidence"": 0.8, ""is_development"": false, ""is_generic"": false, ""subtype"": ""Humanized Mouse""}}","{""cell_lines:Hi-Fi"": [""methods""], ""computational_tools:featureCounts"": [""methods""], ""computational_tools:Flow"": [""methods""], ""computational_tools:BWA"": [""methods""], ""computational_tools:ICE"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""patient_derived_models:NSG"": [""methods""]}",False
10678181,10.1016/s1097-2765(00)80415-3,Nf1 and Gmcsf interact in myeloid leukemogenesis.,Mol Cell,2000,862,6356,4518,0,3,3,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""GraphPad Prism"", ""Prism""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:ImageJ"": {""context"": ""he DRG/nerve roots intact, exposing the spinal cord and dorsal root ganglia (DRG) in 7-month-old mice. Image snapshots of dissected spinal cords with the attached nerves were taken and analyzed using ImageJ. (V.1.53k). A DRG with a diameter >1 mm, measured parallel to the spinal axis, was defined as a tumor. 2.3. Immunofluorescence (IF) and Immunohistochemistry (IHC) Mice were cardiac-perfused with ice-"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false}, ""computational_tools:GraphPad Prism"": {""context"": ""tudent\u2019s  t -tests, one-way or two-way ANOVA with multiple comparisons as appropriate. A  p -value < 0.05 is considered significant. Generation of graphs and statistical analyses were performed using GraphPad Prism v.10."", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false}, ""computational_tools:Prism"": {""context"": "" t -tests, one-way or two-way ANOVA with multiple comparisons as appropriate. A  p -value < 0.05 is considered significant. Generation of graphs and statistical analyses were performed using GraphPad Prism v.10."", ""confidence"": 0.8, ""is_development"": false, ""is_generic"": false}}","{""computational_tools:ImageJ"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:Prism"": [""methods""]}",False
10705390,10.5858/2000-124-0382-AUMFMA,A unique method for mutation analysis of tumor suppressor genes in colorectal carcinomas using a crypt isolation technique.,Arch Pathol Lab Med,2000,1035,8123,2726,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Studio""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:Studio"": {""context"": ""iant calling. Successful sequencing runs generated a FASTQ file for each sample pool and a single genomic variant call file (VCF). Annotation of detected variants was performed using Illumina Variant Studio version 2.2 software (Illumina). Every variant with a variant allele frequency\u2009<\u200910% was filtered and excluded before review. Detected variants were marked with a PASS filter flag if the following criteria were "", ""confidence"": 0.8, ""is_development"": false, ""is_generic"": false}}","{""computational_tools:Studio"": [""methods""]}",False
